Pilot Study to Assess the Credibility of Acupuncture in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Whale, Claudia A; MacLaran, Sarah J A; Whale, Christopher I; Barnett, Mandy

doi:10.1136/aim.2008.000232

Cited by 14 publications

(12 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At that visit, potential subjects who were deemed eligible and provided written, informed consent completed baseline measures and were randomized in a 1:1 fashion to receive either a standard or expanded medical visit. Following the visit, after the study physician left the room, subjects completed the Consultation and Relational Empathy measure [ 21 ] and the Borkovec and Nau Credibility Questionnaire [ 22 ], were randomized in a 1:1 ratio to receive Acidil or placebo, and received their study medication along with instructions for how to take it. Subjects were provided with a two week supply of study medication and a two-week daily symptom diary.…”

Section: Methodsmentioning

confidence: 99%

“…They also completed the Gastroesophageal Reflux Disease Health Related Quality of Life instrument (GERD-HRQL,[ 26 ]) and the Gastrointestinal Symptom Rating Scale (GSRS, [ 27 ]) at both study visits. We used the Borkevec and Nau credibility questionnaire [ 22 ] immediately before and after the physician visit and again at the second study visit to assess subjects’ expectations and beliefs about the treatment they received.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

et al. 2015

View full text Add to dashboard Cite

BackgroundIt is unclear whether the benefits that some patients derive from complementary and integrative medicine (CIM) are related to the therapies recommended or to the consultation process as some CIM provider visits are more involved than conventional medical visits. Many patients with gastrointestinal conditions seek out CIM therapies, and prior work has demonstrated that the quality of the patient-provider interaction can improve health outcomes in irritable bowel syndrome, however, the impact of this interaction on gastroesophageal reflux disease (GERD) is unknown. We aimed to assess the safety and feasibility of conducting a 2x2 factorial design study preliminarily exploring the impact of the patient-provider interaction, and the effect of an over-the-counter homeopathic product, Acidil, on symptoms and health-related quality of life in subjects with GERD.Methods24 subjects with GERD-related symptoms were randomized in a 2x2 factorial design to receive 1) either a standard visit based on an empathic conventional primary care evaluation or an expanded visit with questions modeled after a CIM consultation and 2) either Acidil or placebo for two weeks. Subjects completed a daily GERD symptom diary and additional measures of symptom severity and health-related quality of life.ResultsThere was no significant difference in GERD symptom severity between the Acidil and placebo groups from baseline to follow-up (p = 0.41), however, subjects who received the expanded visit were significantly more likely to report a 50% or greater improvement in symptom severity compared to subjects who received the standard visit (p = 0.01). Total consultation length, perceived empathy, and baseline beliefs in CIM were not associated with treatment outcomes.ConclusionAn expanded patient-provider visit resulted in greater GERD symptom improvement than a standard empathic medical visit. CIM consultations may have enhanced placebo effects, and further studies to assess the active components of this visit-based intervention are warranted.Trial RegistrationClinicalTrials.gov NCT01915173

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

et al. 2015

View full text Add to dashboard Cite

show abstract

“…All potentially relevant full-text articles in English that used dyspnea or breathlessness as an endpoint were included in our critical review. We reviewed nine clinical trials (Table 2), including one descriptive study trial and eight randomised controlled trials (RCTs) [12][13][14][15][16][17][18][19][20] . Two of the RCTs used transcutaneous electrical nerve stimulation over acupoints (Acu-TENS) and the remaining seven trials used standard acupuncture for COPD patients.…”

Section: Th E Clinical Trials Of Acupuncture In Copdmentioning

confidence: 99%

“…The results of studies that assessed outcomes based on the MCID are summarised in Table 3. The two RCTs in which acupuncture treatment did not improve dyspnea used the visual analogue scale to quantify the outcome 16,19 , whereas the Suzuki group's studies used more objective methods to measure the outcome beyond the FEV1, including the MBS, MRCS, SGRQ and 6MWT 12,13,17 . The parameters that exhibited the greatest significant differences following treatment were the MBS, SGRQ and 6MWT, all of which contributed to the significant changes observed in the MCID scores.…”

Section: Critical Appraisal Of the Validity Of Acupuncture In Copd Bamentioning

confidence: 99%

Acupuncture for attenuating dyspnea in patients with chronic obstructive pulmonary disease

Fu¹,

Hsieh²

2013

OA Evidence-Based Medicine

View full text Add to dashboard Cite

Introduction Chronic obstructive pulmonary disease (COPD) is an increasingly serious global health problem that is associated with significant morbidity and mortality. The main pathological feature of COPD is the persistent limitation of respiratory airflow, which leads to fatigue, dyspnea and decreased physical activity. Dyspnea is a cardinal symptom of COPD and increases in severity as the course of COPD progresses. Therefore, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommended in 2011 that COPD assessment should be based on the combination of symptoms, lung function and the risk of exacerbations. Acupuncture has become a popular treatment for various medical conditions. Whether acupuncture can improve lung function and exercise capacity in COPD patients by attenuating the dyspnea and fatigue associated with COPD is unclear. In our review, we discuss the latest assessment criteria for COPD according to the revised GOLD guidelines and summarise the most common outcome measures used to assess COPD patients. We also discuss the results of clinical trials of acupuncture treatment for COPD. The concept of the minimal clinically important difference score of outcome measures in COPD is also addressed. Conclusion COPD is a heterogeneous, multicomponent disease that is associated with significant clinical burden and increasing mortality. Dyspnea is a common symptom. Pulmonary rehabilitation and acupuncture are effective methods of treatment in COPD patients. We call for further studies into acupuncture as a treatment method to further our understanding.

show abstract

“…Acupuncture therapy has been widely used to treat a variety of conditions, such as stroke, [ 5 – 8 ] insomnia, [ 9 ] migraine, [ 10 , 11 ] knee pain, [ 12 – 14 ] neck pain, [ 15 , 16 ] frozen shoulder, [ 17 ] pressure ulcer, [ 18 , 19 ] irritable bowel syndrome, [ 20 ] chronic pelvic pain syndrome, [ 21 ] cancer care, [ 22 ] Alzheimer disease, [ 23 ] and COPD. [ 24 – 26 ] Specifically, acupuncture therapy has been suggested and used to treat patients with COPD in China. [ 24 , 25 ]…”

Section: Introductionmentioning

confidence: 99%

Acupuncture for chronic obstructive pulmonary disease (COPD)

Feng¹,

Wang

et al. 2016

Medicine

View full text Add to dashboard Cite

Background:Acupuncture has been suggested to treat chronic obstructive pulmonary disease (COPD) in China. However, current evidence is insufficient to draw a firm conclusion regarding the effectiveness of acupuncture in COPD. Therefore, this multicenter, randomized, sham-controlled study was designed to evaluate the efficacy of acupuncture for treating patients with COPD.Methods:This is a two-arm, parallel group, multicenter, randomized, sham-controlled trial with concealed allocation, and participants, assessor, and analyst blinding. Seventy-two participants with COPD were recruited and randomly divided into 2 groups (real acupuncture group and sham acupuncture group) in a 1:1 ratio. Patients received either real or sham needling at the same acupoints 3 times weekly for 8 weeks. The primary outcome was dyspnea on exertion evaluated using the 6-minute walk test. In addition, health-related quality of life was also evaluated. Measurements were obtained at baseline and after 8 weeks of treatment.Results:Six-minute walking distance measurements and health-related quality of life were significantly better in the real acupuncture group than that in the sham acupuncture group.Conclusion:The findings suggest that acupuncture can be used as an adjunctive therapy to reduce dyspnea in patients with COPD.

show abstract

Pilot Study to Assess the Credibility of Acupuncture in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Cited by 14 publications

References 12 publications

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

Acupuncture for attenuating dyspnea in patients with chronic obstructive pulmonary disease

Acupuncture for chronic obstructive pulmonary disease (COPD)

Contact Info

Product

Resources

About